Whether a European manufacturer of a sterile-packed device is entering the US, or a US-based OEM is expanding across Europe transatlantic success inevitably brings a new set of operational questions, including:
- How do you maintain product availability and respond to changing demand when customers are thousands of miles away?
- How do you adapt to different regulatory requirements on time without introducing unnecessary complexity?
- How do you support international growth while protecting the operations that already drive success in your home market?
Increasingly, many of the orthopedic OEMs we work with are discovering that addressing these challenges can do more than support growth in one region alone. It can help build a more responsive, resilient, and competitive supply model across the entire business.
Maintaining product availability across long distances
When products must travel across the Atlantic before reaching customers, lead times increase, forecasting becomes more complex, and responding to fluctuations in demand becomes more difficult. Inventory decisions carry greater risk, transportation costs can rise, and flexibility can be reduced.
For orthopedic OEMs, the impact of these challenges is not only logistical.
When sterile-packed implants, instruments, or procedure kits are not available when hospitals and surgeons need them, product availability can influence purchasing decisions, customer confidence, and ultimately market share.
That’s why exploring how to reduce the distance between finished sterile device readiness and customer demand benefits everyone in the healthcare value chain.






